Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma

Molecular Medicine Reports

Volumn 8, Issue 5, 2013, Pages 1353-1358

  Yang, Zhili ^a   Yuan, Ziming ^a   Fan, Youben ^a   Deng, Xianzhao ^a   Zheng, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Aggressiveness; MicroRNA; mRNA; Papillary thyroid carcinoma

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA;

ADULT; ARTICLE; BIOINFORMATICS; CANCER GENETICS; CLINICAL ARTICLE; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FN1 GENE; GENE; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN TISSUE; ITGA2 GENE; MALE; POLYMERASE CHAIN REACTION; RNA ANALYSIS; THYROID PAPILLARY CARCINOMA; TIMP3 GENE; TUMOR INVASION; UPREGULATION; VALIDATION STUDY; ZNFR3 GENE;

ADULT; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HUMANS; LUCIFERASES; MALE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885103436     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1699     Document Type: Article

References (31)

1. Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167, 2006.
2. Hay ID, Thompson GB, Grant CS, et al: Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26: 879-885, 2002.
3. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
4. White NM, Fatoohi E, Metias M, Jung K, Stephan C and Yousef GM: Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Onco 8: 75-84, 2011.
5. Pallante P, Visone R, Croce CM and Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17: F91-F104, 2010.
6. Wilson C: Cancer: MicroRNA expression provides clues about the aggressiveness of papillary thyroid carcinoma. Nat Rev Endocrinol 6: 416, 2010.
7. Vasko V, Espinosa AV, Scouten W, et al: Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104: 2803-2808, 2007.
8. Yang Z, Fan Y, Deng Z, Wu B and Zheng Q: Amyloid precursor protein as a potential marker of malignancy and prognosis in papillary thyroid carcinoma. Oncol Lett 3: 1227-1230, 2012.
9. Stinson S, Lackner MR, Adai AT, et al: miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal 4: 2002258, 2011.
10. Yip L, Kelly L, Shuai Y, et al: MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18: 2035-2041, 2011.
11. Zheng C, Yinghao S and Li J: MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Med Oncol 29: 815-822, 2012.
12. Zhang C, Zhang J, Hao J, et al: High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 10: 119, 2012.
13. Geraldo MV, Yamashita AS and Kimura ET: MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene 31: 1910-1922, 2012.
14. V600E mutation. Thyroid 20: 489-494, 2010.
15. Chou CK, Yang KD, Chou FF, et al: Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab 98: E196-E205, 2013.
16. Guo CJ, Pan Q, Li DG, Sun H and Liu BW: miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 50: 766-778, 2009.
17. Gao Y, Wang C, Shan Z, et al: MiRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness. Endocr J 57: 81-86, 2010.
18. Anania MC, Sensi M, Radaelli E, et al: TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene 30: 3011-3023, 2011.
19. Hao HX, Xie Y, Zhang Y, et al: ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485: 195-200, 2012.
20. Sastre-Perona A and Santisteban P: Role of the Wnt pathway in thyroid cancer. Front Endocrinol (Lausanne) 3: 31, 2012.
21. Ponzo MG, Lesurf R, Petkiewicz S, et al: Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA 106: 12903-12908, 2009.
22. Previdi S, Maroni P, Matteucci E, Broggini M, Bendinelli P and Desiderio MA: Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways. Eur J Cancer 46: 1679-1691, 2010.
23. Strillacci A, Valerii MC, Sansone P, et al: Loss of miR-101 expression promotes Wnt/β-catenin signaling pathway activation and malignancy in colon cancer cells. J Pathol 229: 379-389, 2013.
24. Bandapalli OR, Dihlmann S, Helwa R, et al: Transcriptional activation of the β-catenin gene at the invasion front of colorectal liver metastases. J Pathol 218: 370-379, 2009.
25. Cho SW, Lee EJ, Kim H, et al: Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling. Mol Cell Endocrinol 366: 90-98, 2013.
26. Kalluri R and Weinberg RA: The basics of epithelial - mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
27. Viana Lde S, Affonso RJ Jr, Silva SR, et al: Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination. Oncology 84: 81-91, 2013.
28. Alexi X, Berditchevski F and Odintsova E: The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors. Biochem Soc Trans 39: 568-573, 2011.
29. Foubert P and Varner JA: Integrins in tumor angiogenesis and lymphangiogenesis. Methods Mol Biol 757: 471-486, 2012.
30. Zhang H, Guo F and Zhu G: Involvement of host cell integrin α2 in Cryptosporidium parvum infection. Infect Immun 80: 1753-1758, 2012.
31. Chen J, Liu NN, Li JQ, et al: Association between ITGA2 C807T polymorphism and gastric cancer risk. World J Gastroenterol 17: 2860-2866, 2011.